Caledonia (Private) Investments Pty Ltd: ROYALTY PHARMA PLC (RPRX): Quarterly 13F Position History
As of Q1 2026, Caledonia (Private) Investments Pty Ltd reported 7,168,399 shares of ROYALTY PHARMA PLC (RPRX), worth $343.9M and representing 10.0% of its 13F equity book. Quarter-over-quarter share count change: 208,639 (-2.8%) . The position first appeared in Q1 2025 and has been disclosed across 5 13F-HR filings in Pactolio's tracked window.
- 7,168,399Shares Held (Latest Filing)
- $343.9MReported Market Value (Latest Filing)
- 10.0%Portfolio Weight (% of 13F Equity Book)
- 208,639Quarter-over-Quarter Share Change
- +$58.8MQuarter-over-Quarter Value Change
- 7,547,609Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 5 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 7,168,399 | 208,639 | -2.8% | $343.9M | 10.0% | $48.0 |
| Q4 2025 | 7,377,038 | 170,571 | -2.3% | $285.0M | 5.5% | $38.6 |
| Q3 2025 | 7,547,609 | +1,102,880 | +17.1% | $266.3M | 4.3% | $35.3 |
| Q2 2025 | 6,444,729 | +1,330,162 | +26.0% | $232.2M | 3.7% | $36.0 |
| Q1 2025 | 5,114,567 | — | — | $159.2M | 2.6% | $31.1 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Caledonia (Private) Investments Pty Ltd first disclose a RPRX position in 13F-HR filings?
Caledonia (Private) Investments Pty Ltd first reported ROYALTY PHARMA PLC (RPRX) on its 13F-HR filing for the period ending 2025-03-31 (Q1 2025). The position has appeared on 5 reported quarters within Pactolio's tracked window.
What was Caledonia (Private) Investments Pty Ltd's most recent quarter-over-quarter share-count change in RPRX?
Between Q4 2025 and Q1 2026, Caledonia (Private) Investments Pty Ltd reduced its RPRX position by 208,639 shares (-2.8%), leaving 7,168,399 shares at a market value of $343.9M.
Does the implied price-per-share represent Caledonia (Private) Investments Pty Ltd's cost basis in RPRX?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.